Table of Content

Open Access iconOpen Access

RETRACTION

[ARTICLE WITHDRAWN] Long Noncoding RNA KCNQ1OT1 Accelerates the Progression of Ovarian Cancer via MicroRNA-212-3/LCN2 Axis

by

1 Department of Obstetrics and Gynecology, the Second Affiliated Hospital of Zhengzhou UniversityZhengzhou, HenanP.R. China
2 Education and Training Department, People’s Hospital of Zhengzhou UniversityZhengzhou, HenanP.R. China

Oncology Research 2020, 28(2), 135-146. https://doi.org/10.3727/096504019X15719983040135

Abstract

This article was wihdrawn by the authors with the following Withdrawal Statement - The integrity of the current study is not acceptable. The authors intend to enrich the study to make it more valuable. Thus, the authors want to withdraw the current study. Please accept our apologies for this inconvenience and we hope for your understanding. Yours sincerely (on behalf of the authors), Xiaoqin Lu.

Cite This Article

APA Style
Lu, , Xiaoqin, , Wang, , Fuying, , Fu, et al. (2020). [ARTICLE WITHDRAWN] long noncoding RNA KCNQ1OT1 accelerates the progression of ovarian cancer via microrna-212-3/lcn2 axis. Oncology Research, 28(2), 135-146. https://doi.org/10.3727/096504019X15719983040135
Vancouver Style
Lu , Xiaoqin , Wang , Fuying , Fu , Meizhou , et al. [ARTICLE WITHDRAWN] long noncoding RNA KCNQ1OT1 accelerates the progression of ovarian cancer via microrna-212-3/lcn2 axis. Oncol Res. 2020;28(2):135-146 https://doi.org/10.3727/096504019X15719983040135
IEEE Style
Lu et al., “[ARTICLE WITHDRAWN] Long Noncoding RNA KCNQ1OT1 Accelerates the Progression of Ovarian Cancer via MicroRNA-212-3/LCN2 Axis,” Oncol. Res., vol. 28, no. 2, pp. 135-146, 2020. https://doi.org/10.3727/096504019X15719983040135



cc Copyright © 2020 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 767

    View

  • 503

    Download

  • 0

    Like

Share Link